By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Elcelyx Therapeutics 

San Diego  California    U.S.A.
Phone: n/a Fax: n/a



Company News
Elcelyx Therapeutics Reports Positive Results In Phase 2b Study Of Metformin Delayed Release In Type 2 Diabetes 11/10/2016 3:25:26 PM
Elcelyx Therapeutics Elects Sandy Mahatme To Board Of Directors 10/12/2016 8:48:16 AM
Elcelyx Therapeutics Completes Enrollment In Phase 2b Clinical Trial Of Metformin Delayed Release For Type 2 Diabetes 5/25/2016 6:17:25 AM
SoCal's Elcelyx Therapeutics Reels in $40 Million 10/1/2015 5:59:22 AM
Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabetes 10/21/2013 8:48:10 AM
Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting 9/17/2013 9:27:39 AM
Elcelyx Therapeutics' NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study 9/4/2013 9:57:19 AM
NaZura BioHealth Spun-Out From Elcelyx Therapeutics to Advance Lovidia for Weight Management 9/4/2013 6:56:09 AM
Elcelyx Therapeutics' Study Shows NewMet Has Better Glucose-Lowering Effects Than Metformin 6/24/2013 6:49:27 AM
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions 6/17/2013 8:43:24 AM